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Background: A myocardial infarction (MI) (‘heart attack’) can be intensely stressful, and the impact of this event can
leave patients with clinically significant post-MI stress symptoms. Untreated stress can make heart disease worse.
Few tools are available that screen for specific thoughts or beliefs that can trigger post-MI stress responses. In other
life-threatening illnesses, fear of recurrence (FoR) of illness has been identified as a key stressor, and screening tools
have been developed to identify this. The aim of this review is to identify FoR screening tools used in other
common life-threatening diseases that report on the development of the tool, to assess if there are any that can be
adapted for use in MI survivors so that those with high levels of FoR can be identified and helped.
Methods/Design: The review will evaluate full FoR screening tools and methods of measurement used in common
life-threatening disease clinical populations. The Campbell and Cochrane Libraries, Cumulative Index of Nursing and
Allied Health Literature (CINAHL), PsycINFO, MEDLINE, Embase, Applied Social Sciences Index and Abstracts (ASSIA),
Published International Literature on Traumatic Stress (PILOTS), Social Services Abstracts, Sociological Abstracts, Web
of Knowledge, Health and Psychosocial Instruments and SCOPUS databases will be searched for relevant studies
published from database inception. Reference lists and published reviews/meta-analyses will also be searched. All
titles and abstracts will be screened and relevant full-text versions retrieved by two reviewers, who will then extract
all the data. Each will independently review all data extracted by the other. Selected studies will also be assessed by
two independent researchers using the COnsensus-based standards for the Selection of health status measurement
INstruments (COSMIN) checklist and other quality criteria. This will be done to evaluate the degree to which their
measurement properties meet the standards for good methodological quality. Disagreement will be resolved
through consensus.
Discussion: Untreated post-MI stress has a considerable psychological and physical impact on MI survivors. Therefore,
there is a critical need to develop a screening tool to identify fear of recurrent MI so that those affected can be
identified and directed to appropriate support interventions. This proposed research will enable a tool to be developed
and adapted for use in the MI survivor patient population.
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In the UK, there are over 100,000 incidences of myocar-
dial infarctions (MI) every year, with a post-MI 30-day
discharge survival rate of over 90% [1]. Scotland has one
of the highest rates of MI in the world, despite a re-
ported 25% reduction in incidence between 2000 and
2009 [2]. Over the last 15 years, specific interventions
(coronary angioplasty, drugs, devices and cardiac re-
habilitation) have considerably reduced MI-related mor-
tality rates [3,4].
Yet despite the improvements in treatment strategies,
the experience of having an MI can be intensely stressful
and frightening for many patients and the psychological
impact of this event can be long lasting [5-8]. Clinically
significant post-MI stress symptoms are thought to be
present in up to 12.5% (one in eight) patients, and evi-
dence indicates that the post-trauma stress may increase
patients risk for subsequent cardiac events and mortality
[9]. Even transient stress and anxiety appear to be asso-
ciated with poorer longer-term outcomes [10] and short-
term cardiovascular post-stress recovery rates [11].
Moreover, even cardiac patients with less clinically obvi-
ous, mild to moderate low mood, stress and anxiety are at
risk of adverse outcomes, with evidence indicating that it
is not simply the case (as has been argued in the past),
that these elements merely co-exist alongside the patho-
physiological effects, but rather that these mild to moder-
ate elements and adverse cardiovascular reactions may
indeed share a common (but as yet unidentified) under-
lying pathophysiological mechanism [12,13]. Therefore,
screening for modifiable psychological triggers of stress in
post-MI patients to identify patients at risk is crucial to
improving longer-term physical and psychological re-
covery. However, to date, few tools are available which
allow cardiology service providers to screen and iden-
tify MI survivors for specific thoughts or beliefs that
can trigger modifiable stress responses. In contrast, in
other life-threatening illnesses such as cancer, ‘fear of
illness recurrence’ has been identified as a key trigger
of stress in patients and screening tools to identify this
specific stressor have been developed [14-17].
Given the risk and impact of untreated post-MI stress,
the development of a similar screening tool which can
identify fear of recurrent MI in post-MI patients is
therefore critical. In order for such a tool to be devel-
oped, it is necessary to identify and evaluate the quality
of screening tools used to detect fear of recurrent illness
in other common life-threatening diseases to find out if
any existing fear of recurrence (FoR) tools can be
adapted for use in post-MI patients. This evaluation will
inform the development of a theory and evidence-based
screening tool which can assess fear of recurrence in MI
survivors to enable patients at risk to be directed to appro-
priate support and intervention. This proposed systematicreview of the fear of recurrent illness literature aims to do
just this.
Study aims
The primary aim is to identify any fear of recurrent ill-
ness screening tools used in cancer, stroke, asthma and
acute coronary syndrome patient populations and assess
the quality of each tool to assess if there are any tools
that can be adapted for FoR MI screening in MI
survivors.
The secondary aim is to look at psychometric charac-
teristics of FoR screening tools so that adaptations are
only made to good quality and well-developed tools.
Methods/Design
Design
The review will evaluate FoR screening tools and methods
of measurement in different clinical populations (cancer,
stroke, asthma and acute coronary syndrome). Acute cor-
onary syndrome encompasses a range of unstable coronary
artery disease ranging from unstable angina to myocardial
infarction [18]. These clinical populations are chosen be-
cause they are the most common life-threatening diseases
in the UK, and survival from first occurrence and primary
treatment has improved [19-22], but there is still risk of re-
currence. Thus, FoR screening tools are important for
these clinical populations.
Strategy
An evidence synthesis of literature focusing on FoR in
the most common life-threatening diseases in the UK
will be conducted. Although existing literature identifies
FoR as a common problem in cancer survivors, to date,
there appears to be a lack of consensual definition of the
phenomenon in the existing research [17]. Furthermore,
the theoretical concept of FoR is currently unexplored in
the MI survivor population. Therefore, for the purpose
of this review, which is to examine the psychometric
characteristics of FoR screening tools and assess poten-
tial transferability of FoR items, domains and constructs
to a different survivor population, only FoR screening
tools with >3 items will be included. Tools with less than
three items tend to psychometrically unstable as with
fewer items, cross-validation of factor structures be-
comes difficult [23]. Also, more comprehensive tools (>3
items) should offer greater sensitivity and granularity for
the purposes of assessing potential transferability of
meaningful and clinically relevant domains and items to
a different survivor population. Sub-scales will be ex-
cluded as in existing FoR research, understanding of
what existing sub-scales are measuring may be limited at
this time, particularly as the most widely used sub-scale
screening tools used for measuring patients’ point of
view are typically derived from earlier longer versions of
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to single items and domains without clear rationale for
the non-standardised characteristics [25]. And as shorter
versions typically reduce the original multiple items within
a domain to single items, sub-scales cover a narrower
range of precision and concept sensitivity because of this
aggregation [26].
Systematic searches will be conducted across relevant
health databases (Campbell and Cochrane Library, Cumu-
lative Index of Nursing and Allied Health Literature
(CINAHL), PsycINFO, MEDLINE, Embase, ASSIA, PI-
LOTS, Social Services Abstracts, Sociological Abstracts,
Web of Knowledge, Health and Psychosocial Instruments
and SCOPUS) published in peer-reviewed journals from
database inception (Table 1). Reference lists and published
reviews/meta-analyses will also be searched. StudiesTable 1 Example search using subject headings
Search strategy
1 exp neoplasms/(2693021)
2 exp recurrence/(165159)
3 exp Neoplasm Recurrence, Local/(86083)
4 exp asthma/(109453)
5 exp stroke/(91990)
6 exp acute coronary syndrome/(8195)
7 2 or 3 (250583)
8 1 or 4 or 5 or 6 (2897701)
9 7 and 8 (116674)
10 exp emotions/(176489)
11 9 and 10 (261)
12 (cancer: or neoplasm: or oncol: or asthm:
or stroke or strokes or acute coronary syndrom:
or cardio: or cardia: or coronary).af. (4339611)
13 (recur: or rec-cur: or reocur: or re-ocur: or relaps:
or reappear: or re appear).af. (585938)
14 (fear: or worr: or anx: or distress: or emotion:
or apprehens: or dread or panic:).af. (411973)
15 12 and 13 and 14 (3417)
16 ((questionnair: or scal: or screen: or psychometric:)
and (valid: or reliab:)).af. (151160)
17 15 and 16 (113)
18 17 not 11 (86)
Database: Ovid MEDLINE(R) 1946 to Present with Daily Update.
Example search using keywords: Strategy used in ASSIA/PILOTS/Social Services
Abstracts and Sociological Abstracts.
(cancer* OR neoplasm* OR oncol* OR asthm* OR stroke OR strokes OR acute
coronary syndrom* OR cardio* OR cardia* OR coronary) AND (recur* OR rec-
cur* OR reocur* OR re-ocur* OR relaps* OR reappear* OR re appear) AND (fear*
OR worr* OR anx* OR distress* OR emotion* OR apprehens* OR dread OR
panic*) AND (questionnair* OR scal* OR screen* OR Psychometric*) AND (valid*
OR reliab*).
Strategy used in the non-structured databases.
(Myocardial infaction*) and (recur* or rec-cur* or reocur* or re-ocur* or relaps*
or reappear* or re appear*) and (fear* or worr* or anx* or distress* or emotion*
or apprehens* or dread or panic*).involving the development of fear of illness recurrence
screening or measurement tools will be evaluated. All ti-
tles and abstracts will be screened and relevant full-text
versions retrieved by two reviewers.Inclusion criteria
All titles and abstracts will be screened and relevant full-
text versions retrieved and assessed by two reviewers
(Table 2). The following inclusion criteria will be ap-
plied: 1) studies that report on the development of
screening tools used to measure fear of recurrent illness
in life-threatening diseases (must include >3 items); 2)
the study population should be adults diagnosed with
cancer, stroke, asthma or acute coronary syndrome over
18 years of age; and 3) published in a peer-reviewed
journal. Disagreements will be resolved through consen-
sus, and the level of agreement will be reported and lim-
itations acknowledged. All exclusion decisions will be
reported.
Data extraction
A data extraction form will standardise the data extrapo-
lated from each paper (Table 3). As health measurement
instrument development lacks consensus at present and
often includes different ways to measure a given con-
struct, screening tools can vary widely in content,
method and quality [27]. This means the fragmented
health measurement literature is often non-comparable.
Therefore, for the purposes of this review, we will adopt
a ‘holistic’ approach to contrasting and comparing iden-
tified relevant tools, and narratively report on relevant
quality or methodological properties relevant to the aim
of this review. This approach will take into account quality
measurements so that useful comparisons of quality can
be made. In addition, design data will be extracted and
summarised so that adaptations are only made to good
quality and well-developed tools. Two researchers willTable 2 Inclusion selection form
Inclusion selection form
1. Paper number
2. First author
3. Reviewer
Q1. Does the study report on the
development of a screening tool used to
screen for fear of recurrent illness?
Yes ⎕ Go to Q2. No.
Reject study.
Q2. Does the screening tool include > 3 items
measuring fear of recurrent illness?
Yes ⎕ Go to Q3. No.
Reject study.
Q3. Is the population adult patients in cancer,
stroke, asthma or acute coronary syndrome?
Yes ⎕ Go to Q4. No.
Reject study.
Q4. Is the study published in a peer-reviewed
journal between 1946 - present?
Yes ⎕ Retain study. No.
Reject study.
Table 3 Data extraction items (in addition to COSMIN
data extracted and reported)
Descriptive information Screening tool characteristics
Screening tool Number of items
Clinical population Number and types of domains
Sample size Theoretical/conceptual framework
Disease stage Response format/scale design
Country and setting Tool development process
Type of instrument
(e.g., PRO)
Validity (types of texts/results)
Reliability
Response rates
Utility in administration and interpretation
(including ceiling and floor scores)
Range and number of raters required
for scoring and analysis
Mode of administration (e.g., self-completed)
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extracted by the other and agree, through consensus, the
accuracy and completeness of the data. Where consensus
is difficult to reach, a third researcher will be consulted to
reach agreement.Figure 1 The four-step procedure to complete the COSMIN checklist.Study quality
Selected studies will also be assessed by two independent
researchers using the COnsensus-based Standards for
the selection of health status measurement INstruments
(COSMIN) checklist to evaluate the degree to which
their measurement properties meet the standards for
good methodological quality. Disagreement will be re-
solved through consensus. The COSMIN checklist con-
tains standards for design requirements and preferred
statistical methods of studies on the measurement prop-
erties of health measurement instruments. The checklist
can be used to determine if a study on measurement
properties meets the standards for good methodological
quality and has been developed by international experts
in the field of health status measurement [28]. It is de-
signed to evaluate the methodological quality of studies
that report on psychometric properties for inclusion in a
systematic review, even if the studies have conducted
different validity and reliability tests. Each item of the
COSMIN checklist data extraction form offers four pos-
sible response options (‘excellent’, ‘good’, ‘fair’, ‘poor’) in
relation to methodological quality and the score ob-
tained by taking the lowest rating of any item (Figure 1)
[29]. This will allow us to report on the overall
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view if sufficient data is reported in each publication.
Data analysis
As study methods and development processes are antici-
pated to be heterogeneous, pooling of measurement tool
properties is not possible. Therefore, synthesis of data will
be primarily reported in words and text where appropriate,
to summarise and explain the findings and content of mul-
tiple studies in narrative format. This synthesis will be
based on the general framework and tools outlined in the
ESRC Guidance on the Conduct of Narrative Synthesis in
Systematic Reviews [30]. Relevant extracted study data in-
cluding COSMIN ratings will be tabulated in a hierarchical
rating of quality and individual instruments will be cate-
gorised in terms of relevant and comparable design features
or characteristics [31].
Discussion
Given the risk and consequences of untreated post-MI
stress, the impact of this planned systematic review of fear
of recurrent illness screening tools in common life-
threatening diseases is expected to be high, as there is cur-
rently no fear of recurrent MI screening tool available.
Therefore, there is a critical need to develop a screening
tool to identify fear of recurrent MI in the MI survivor
population so that post-MI patients with this fear can be
identified and directed to appropriate support interven-
tions. This proposed research will provide the best possible
evidence to provide a foundation for the development of a
fear of recurrent MI screening tool, by systematically and
‘holistically’ evaluating which fear of recurrence tools work,
why they work and for whom. Thus, this research will en-
able an evidence and theory-based screening tool to be de-
veloped and adapted for use in the MI survivor patient
population. This systematic review is timely and will make
a valuable contribution to improving post-MI patient care.
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